375 related articles for article (PubMed ID: 31684987)
1. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective.
Beerepoot S; Nierkens S; Boelens JJ; Lindemans C; Bugiani M; Wolf NI
Orphanet J Rare Dis; 2019 Nov; 14(1):240. PubMed ID: 31684987
[TBL] [Abstract][Full Text] [Related]
2. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.
van Rappard DF; Boelens JJ; Wolf NI
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):261-73. PubMed ID: 25987178
[TBL] [Abstract][Full Text] [Related]
3. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy as the sole initial finding in three children with infantile metachromatic leukodystrophy.
Haberlandt E; Scholl-Bürgi S; Neuberger J; Felber S; Gotwald T; Sauter R; Rostasy K; Karall D; Korinthenberg R
Eur J Paediatr Neurol; 2009 May; 13(3):257-60. PubMed ID: 18571943
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and LRP1 polymorphisms in patients with different clinical types of metachromatic leukodystrophy.
Ługowska A; Musielak M; Jamroz E; Pyrkosz A; Kmieć T; Tylki-Szymańska A; Bednarska-Makaruk M
Gene; 2013 Sep; 526(2):176-81. PubMed ID: 23701968
[TBL] [Abstract][Full Text] [Related]
6. Saposin B-Deficient Metachromatic Leukodystrophy Mimicking Acute Flaccid Paralysis.
Madaan P; Jauhari P; Chakrabarty B; Kumar A; Gulati S
Neuropediatrics; 2019 Oct; 50(5):318-321. PubMed ID: 31319425
[TBL] [Abstract][Full Text] [Related]
7. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
Sevin C; Aubourg P; Cartier N
J Inherit Metab Dis; 2007 Apr; 30(2):175-83. PubMed ID: 17347913
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
9. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series.
Beerepoot S; Boelens JJ; Lindemans C; de Witte MA; Nierkens S; Vrancken AFJE; van der Knaap MS; Bugiani M; Wolf NI
J Neurol; 2024 Apr; ():. PubMed ID: 38564053
[TBL] [Abstract][Full Text] [Related]
10. Isolated peripheral neuropathy in atypical metachromatic leukodystrophy: a recurrent mutation.
Coulter-Mackie MB; Applegarth DA; Toone JR; Gagnier L; Anzarut AR; Hendson G
Can J Neurol Sci; 2002 May; 29(2):159-63. PubMed ID: 12035837
[TBL] [Abstract][Full Text] [Related]
11. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene.
Marcão AM; Wiest R; Schindler K; Wiesmann U; Weis J; Schroth G; Miranda MC; Sturzenegger M; Gieselmann V
Arch Neurol; 2005 Feb; 62(2):309-13. PubMed ID: 15710861
[TBL] [Abstract][Full Text] [Related]
12. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
13. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
14. Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy.
Virgens MY; Siebert M; Bock H; Burin M; Giugliani R; Saraiva-Pereira ML
Gene; 2015 Aug; 568(1):69-75. PubMed ID: 25965562
[TBL] [Abstract][Full Text] [Related]
15. The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review.
Chang SC; Eichinger CS; Field P
Eur J Med Res; 2024 Mar; 29(1):181. PubMed ID: 38494502
[TBL] [Abstract][Full Text] [Related]
16. Atidarsagene autotemcel for metachromatic leukodystrophy.
Messina M; Gissen P
Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
[TBL] [Abstract][Full Text] [Related]
17. Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation.
Shahzad MA; Khaliq S; Amar A; Mahmood S
J Mol Neurosci; 2017 Sep; 63(1):84-90. PubMed ID: 28799099
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new Arylsulfatase A (ARSA) gene mutation in Tunisian patients with metachromatic leukodystrophy (MLD).
Dorboz I; Eymard-Pierre E; Kefi R; Abdelhak S; Miladi N; Boespflug-Tanguy O;
J Neurol Sci; 2009 Dec; 287(1-2):278-80. PubMed ID: 19699491
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathy in metachromatic leucodystrophy. A study of 40 cases from south India.
Bindu PS; Mahadevan A; Taly AB; Christopher R; Gayathri N; Shankar SK
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1698-701. PubMed ID: 16291896
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
